FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130697125> ?p ?o ?g. }

• W2130697125 endingPage "1866" @default.
• W2130697125 startingPage "1857" @default.
• W2130697125 abstract "To evaluate chronic kidney disease (CKD)-associated anemia management challenges and limitations and discuss strategies to improve treatment rates and patient response to therapy, monitoring of patient response to therapy, and education of prescribing providers and patients.Multiple MEDLINE searches were performed using a comprehensive search term list to identify studies for inclusion, including, but not limited to, anemia, erythropoiesis-stimulating agent (ESA), epoetin, darbepoetin, CERA, hemoglobin, CKD, dialysis, end-stage renal disease, quality of life, and pharmacist. Annual data reports and clinical practice guidelines published by the National Kidney Foundation and US Renal Data System were included. Information provided within product package inserts for recombinant human erythropoietin (epoetin alfa; Epogen, Procrit) and darbepoetin alfa (Aranesp) were also included.Only articles that were published in English and were relevant for this review were included.Anemia is a common complication of CKD, with significant impact on patients' quality of life. Anemia of CKD represents a significant burden on the healthcare system, with ESA use resulting in substantial financial costs. As new therapies, formularies, and dosing regimens evolve, the collaborative role of the clinical pharmacist is integral to a multidisciplinary treatment strategy, both in the inpatient and outpatient settings, such as hospitals or dialysis centers, respectively. This review focuses on initial and target hemoglobin (Hb) concentrations, as well as patient characteristics, treatment preferences, and dosing schedules, which are important considerations in managing CKD-associated anemia. To ensure effective therapeutic strategies, a patient-centered approach is required. Pharmacists are ideally positioned to help select ESA therapy, influence formulary use, educate healthcare professionals and patients, develop and implement dosing and monitoring protocols, and possibly promote quality improvement.An approach to CKD-associated anemia management that involves collaboration with pharmacists is essential to achieve patient-specific, cost-effective ESA therapy." @default.
• W2130697125 created "2016-06-24" @default.
• W2130697125 creator A5010585475 @default.
• W2130697125 creator A5016502106 @default.
• W2130697125 creator A5022193691 @default.
• W2130697125 creator A5071766699 @default.
• W2130697125 date "2009-10-13" @default.
• W2130697125 modified "2023-09-23" @default.
• W2130697125 title "Meeting New Challenges in the Management of Anemia of Chronic Kidney Disease Through Collaborative Care with Pharmacists" @default.
• W2130697125 cites W1904695471 @default.
• W2130697125 cites W1968928439 @default.
• W2130697125 cites W1977252836 @default.
• W2130697125 cites W1983560550 @default.
• W2130697125 cites W1993170101 @default.
• W2130697125 cites W1995563191 @default.
• W2130697125 cites W1996588708 @default.
• W2130697125 cites W2004714428 @default.
• W2130697125 cites W2012766458 @default.
• W2130697125 cites W2015448181 @default.
• W2130697125 cites W2015555551 @default.
• W2130697125 cites W2018901137 @default.
• W2130697125 cites W2033601942 @default.
• W2130697125 cites W2033803279 @default.
• W2130697125 cites W2035913846 @default.
• W2130697125 cites W2039344431 @default.
• W2130697125 cites W2040029744 @default.
• W2130697125 cites W2049843297 @default.
• W2130697125 cites W2052437363 @default.
• W2130697125 cites W2056508624 @default.
• W2130697125 cites W2057109685 @default.
• W2130697125 cites W2072976749 @default.
• W2130697125 cites W2073632784 @default.
• W2130697125 cites W2076374133 @default.
• W2130697125 cites W2082382250 @default.
• W2130697125 cites W2085599162 @default.
• W2130697125 cites W2087013971 @default.
• W2130697125 cites W2088028867 @default.
• W2130697125 cites W2089264894 @default.
• W2130697125 cites W2090982069 @default.
• W2130697125 cites W2094875169 @default.
• W2130697125 cites W2098826958 @default.
• W2130697125 cites W2099367954 @default.
• W2130697125 cites W2103517401 @default.
• W2130697125 cites W2104416692 @default.
• W2130697125 cites W2106428825 @default.
• W2130697125 cites W2108037737 @default.
• W2130697125 cites W2113686501 @default.
• W2130697125 cites W2114505956 @default.
• W2130697125 cites W2115009441 @default.
• W2130697125 cites W2115592617 @default.
• W2130697125 cites W2119693151 @default.
• W2130697125 cites W2130240434 @default.
• W2130697125 cites W2134487085 @default.
• W2130697125 cites W2135819931 @default.
• W2130697125 cites W2141434615 @default.
• W2130697125 cites W2143960546 @default.
• W2130697125 cites W2144758554 @default.
• W2130697125 cites W2150235415 @default.
• W2130697125 cites W2158722347 @default.
• W2130697125 cites W2159297516 @default.
• W2130697125 cites W2161519672 @default.
• W2130697125 cites W2163489576 @default.
• W2130697125 cites W2312781834 @default.
• W2130697125 cites W2321111200 @default.
• W2130697125 cites W2331794966 @default.
• W2130697125 cites W2412004141 @default.
• W2130697125 cites W2416367955 @default.
• W2130697125 cites W65817400 @default.
• W2130697125 cites W1975096290 @default.
• W2130697125 cites W2039924611 @default.
• W2130697125 cites W3149132779 @default.
• W2130697125 doi "https://doi.org/10.1345/aph.1m035" @default.
• W2130697125 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19826095" @default.
• W2130697125 hasPublicationYear "2009" @default.
• W2130697125 type Work @default.
• W2130697125 sameAs 2130697125 @default.
• W2130697125 citedByCount "2" @default.
• W2130697125 countsByYear W21306971252013 @default.
• W2130697125 countsByYear W21306971252022 @default.
• W2130697125 crossrefType "journal-article" @default.
• W2130697125 hasAuthorship W2130697125A5010585475 @default.
• W2130697125 hasAuthorship W2130697125A5016502106 @default.
• W2130697125 hasAuthorship W2130697125A5022193691 @default.
• W2130697125 hasAuthorship W2130697125A5071766699 @default.
• W2130697125 hasConcept C100406419 @default.
• W2130697125 hasConcept C104863432 @default.
• W2130697125 hasConcept C126322002 @default.
• W2130697125 hasConcept C159110408 @default.
• W2130697125 hasConcept C177713679 @default.
• W2130697125 hasConcept C2776164570 @default.
• W2130697125 hasConcept C2777288759 @default.
• W2130697125 hasConcept C2778248108 @default.
• W2130697125 hasConcept C2778534260 @default.
• W2130697125 hasConcept C2778653478 @default.
• W2130697125 hasConcept C2779457091 @default.
• W2130697125 hasConcept C2779951463 @default.
• W2130697125 hasConcept C2779978075 @default.
• W2130697125 hasConcept C2781404941 @default.

• next